These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 28214102)

  • 1. Vitreomacular Adhesion and the Risk of Neovascular Age-Related Macular Degeneration.
    Maggio E; Polito A; Guerriero M; Prigione G; Parolini B; Pertile G
    Ophthalmology; 2017 May; 124(5):657-666. PubMed ID: 28214102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prevalence of vitreomacular adhesion in eyes with macular oedema secondary to retinal vein occlusion selected for intravitreal injections.
    Maggio E; Maraone G; Mete M; Vingolo EM; Grenga PL; Guerriero M; Pertile G
    Acta Ophthalmol; 2021 Nov; 99(7):e1154-e1161. PubMed ID: 33421346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitreomacular adhesion in active and end-stage age-related macular degeneration.
    Robison CD; Krebs I; Binder S; Barbazetto IA; Kotsolis AI; Yannuzzi LA; Sadun AA; Sebag J
    Am J Ophthalmol; 2009 Jul; 148(1):79-82.e2. PubMed ID: 19327744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of Vitreomacular Adhesion on Anti-Vascular Endothelial Growth Factor Treatment for Neovascular Age-Related Macular Degeneration.
    Kanadani TCM; Dos Reis Veloso CE; Dorairaj S; Nehemy MB
    Ophthalmic Res; 2017; 58(1):18-26. PubMed ID: 28301850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of abnormal vitreomacular adhesion in age-related macular degeneration: spectral optical coherence tomography and surgical results.
    Mojana F; Cheng L; Bartsch DU; Silva GA; Kozak I; Nigam N; Freeman WR
    Am J Ophthalmol; 2008 Aug; 146(2):218-227. PubMed ID: 18538742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Posterior vitreomacular adhesion and risk of exudative age-related macular degeneration: paired eye study.
    Lee SJ; Lee CS; Koh HJ
    Am J Ophthalmol; 2009 Apr; 147(4):621-626.e1. PubMed ID: 19159862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of Posterior Vitreous Detachment and Vitreomacular Adhesion in Patients With Age-Related Macular Degeneration.
    Ilim O; Akkin C; Oztas Z; Nalcaci S; Afrashi F; Degirmenci C; Mentes J
    Ophthalmic Surg Lasers Imaging Retina; 2017 Mar; 48(3):223-229. PubMed ID: 28297034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of vitreomacular adhesion on the development of exudative age-related macular degeneration: 4-year results of a longitudinal study.
    Waldstein SM; Sponer U; Simader C; Sacu S; Schmidt-Erfurth U
    Retina; 2012 Mar; 32(3):424-33. PubMed ID: 22105497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of the Vitreomacular Interface on Treatment Outcomes in the Comparison of Age-Related Macular Degeneration Treatments Trials.
    Ciulla TA; Ying GS; Maguire MG; Martin DF; Jaffe GJ; Grunwald JE; Daniel E; Toth CA;
    Ophthalmology; 2015 Jun; 122(6):1203-11. PubMed ID: 25824327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ASSOCIATION BETWEEN THE VITREOMACULAR INTERFACE AND OPTICAL COHERENCE TOMOGRAPHY CHARACTERISTICS IN WET AGE-RELATED MACULAR DEGENERATION.
    Ashraf M; Souka A; Adelman RA
    Retina; 2017 Sep; 37(9):1738-1745. PubMed ID: 28005632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Vitreomacular interface and posterior vitreomacular adhesion in exudative age-related macular degeneration (AMD): an OCT-based comparative study].
    Maier M; Pfrommer S; Burzer S; Feucht N; Winkler von Mohrenfels C; Lohmann CP
    Klin Monbl Augenheilkd; 2012 Oct; 229(10):1030-5. PubMed ID: 23096146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Posterior vitreomacular adhesion: a potential risk factor for exudative age-related macular degeneration?
    Krebs I; Brannath W; Glittenberg C; Zeiler F; Sebag J; Binder S
    Am J Ophthalmol; 2007 Nov; 144(5):741-746. PubMed ID: 17884003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of Fellow Eye Involvement in Patients With Unilateral Exudative Age-Related Macular Degeneration.
    Yanagi Y; Mohla A; Lee SY; Mathur R; Chan CM; Yeo I; Wong TY; Cheung CMG
    JAMA Ophthalmol; 2018 Aug; 136(8):905-911. PubMed ID: 29879284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitreomacular Interface after Anti-Vascular Endothelial Growth Factor Injections in Neovascular Age-Related Macular Degeneration.
    Veloso CE; Kanadani TM; Pereira FB; Nehemy MB
    Ophthalmology; 2015 Aug; 122(8):1569-72. PubMed ID: 26038338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of vitreomacular adhesion on anti-vascular endothelial growth factor treatment for exudative age-related macular degeneration.
    Lee SJ; Koh HJ
    Ophthalmology; 2011 Jan; 118(1):101-10. PubMed ID: 20678805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of Nonexudative Choroidal Neovascularization and Progression to Exudative Choroidal Neovascularization Using OCT Angiography.
    Bailey ST; Thaware O; Wang J; Hagag AM; Zhang X; Flaxel CJ; Lauer AK; Hwang TS; Lin P; Huang D; Jia Y
    Ophthalmol Retina; 2019 Aug; 3(8):629-636. PubMed ID: 31068262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitreomacular interface in typical exudative age-related macular degeneration and polypoidal choroidal vasculopathy.
    Nomura Y; Ueta T; Iriyama A; Inoue Y; Obata R; Tamaki Y; Yamaguchi T; Yanagi Y
    Ophthalmology; 2011 May; 118(5):853-9. PubMed ID: 21095010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. INFLUENCE OF VITREOMACULAR INTERFACE ON ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY USING TREAT AND EXTEND TREATMENT PROTOCOL FOR AGE-RELATED MACULAR DEGENERATION (VINTREX).
    Houston SK; Rayess N; Cohen MN; Ho AC; Regillo CD
    Retina; 2015 Sep; 35(9):1757-64. PubMed ID: 26110596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age-related macular degeneration and risk factors for the development of choroidal neovascularisation in the fellow eye: a 3-year follow-up study.
    Silva R; Cachulo ML; Fonseca P; Bernardes R; Nunes S; Vilhena N; Faria de Abreu JR
    Ophthalmologica; 2011; 226(3):110-8. PubMed ID: 21822000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of the vitreomacular interface on outcomes of ranibizumab therapy in neovascular age-related macular degeneration.
    Mayr-Sponer U; Waldstein SM; Kundi M; Ritter M; Golbaz I; Heiling U; Papp A; Simader C; Schmidt-Erfurth U
    Ophthalmology; 2013 Dec; 120(12):2620-2629. PubMed ID: 23870300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.